Rousselot Biomedical - advancing medical science

White Paper

Rousselot low endotoxin gelatins and collagens for biomedical applications

February 9, 2022

This whitepaper outlines the benefits of gelatin and collagen for (bio)medical applications and highlights the importance of low endotoxin levels for optimal API (Active Pharmaceutical Ingredients) delivery and (bio)medical engineering materials. The paper also highlights the value-added expertise that Rousselot can offer to researchers, developpers and manufacturers of (bio)medical applications of gelatin, hydrolyzed gelatin and collagen.

Download to find out more.